[go: up one dir, main page]

HK40108118A - Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein - Google Patents

Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein Download PDF

Info

Publication number
HK40108118A
HK40108118A HK42024093933.0A HK42024093933A HK40108118A HK 40108118 A HK40108118 A HK 40108118A HK 42024093933 A HK42024093933 A HK 42024093933A HK 40108118 A HK40108118 A HK 40108118A
Authority
HK
Hong Kong
Prior art keywords
synuclein
aggregation
diagnosis
alpha
prevention
Prior art date
Application number
HK42024093933.0A
Other languages
Chinese (zh)
Inventor
Armin Giese
Felix Schmidt
Daniel WECKBECKER
Andrei Leonov
Sergey Ryazanov
Christian Griesinger
Bernd Pichler
Kristina HERFERT
Andreas Maurer
Laura KÜBLER
Sabrina BUSS
Original Assignee
Modag Gmbh
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modag Gmbh, MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. filed Critical Modag Gmbh
Publication of HK40108118A publication Critical patent/HK40108118A/en

Links

HK42024093933.0A 2019-11-19 2024-07-10 Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein HK40108118A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19210073 2019-11-19

Publications (1)

Publication Number Publication Date
HK40108118A true HK40108118A (en) 2024-11-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP3934652A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3675859A4 (en) Compounds, compositions, and methods for the treatment of disease
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
WO2017181079A3 (en) Methods for monitoring and treating cancer
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
EP3661502A4 (en) Compounds for the prevention and treatment of medical disorders and uses thereof
EP3846843A4 (en) Compositions and methods for the treatment of heart disease
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
EP4037684A4 (en) Medicinal cognitive treatments
EP4043012A4 (en) Drug for treating artery-related diseases, and use thereof
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
WO2018211323A8 (en) Heterocyclic compounds for the treatment of disease
HK40108118A (en) Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein
WO2015162552A3 (en) Composition for topic use
GB201911728D0 (en) Bacterial composistions for the treatment of disease
EP3704485A4 (en) Diagnostic and therapeutic methods for type 2 diabetes
WO2019150050A8 (en) Dimers of factor x variants
EP3732204A4 (en) Anti-renalase antibodies for the treatment and prevention of diseases and disorders
HK40066286A (en) Compounds, compositions, and methods for the treatment of disease
HK40122845A (en) New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild)
HK40073270A (en) Diagnosis and treatment
HK40072946A (en) Novel molecules for therapy and diagnosis
GB201904810D0 (en) The treatment of protein aggregation diseases
HK40109502A (en) Anti-renalase antibodies for the treatment and prevention of diseases and disorders